Mannitol/Sucralose

甘露醇/三氯蔗糖

Report date: 2025/07/31 17:26:21

Base Information

Drug NameMannitol/Sucralose

Drug Alias NameTynadoteSNP-820HUYPS-02/HUYPS-04

ClassificationSmall molecules

Mechanisms of ActionUndefined mechanism

TargetsNot applicable

Therapy Area/IndicationsHepatitisMetabolic Dysfunction-Associated Steatotic Liver DiseaseLiver Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsYes

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSinew Pharma Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHepatitisLiver Diseases

Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

ATC CodeN/A